CoMEt: A Statistical Approach to Identify Combinations of Mutually Exclusive Alterations in Cancer
Preprint
Abstract
Cancer is a heterogeneous disease with different combinations of genetic and epigenetic alterations driving the development of cancer in different individuals. While these alterations are believed to converge on genes in key cellular signaling and regulatory pathways, our knowledge of these pathways remains incomplete, making it difficult to identify driver alterations by their recurrence across genes or known pathways. We introduce Combinations of Mutually Exclusive Alterations (CoMEt), an algorithm to identify combinations of alterations de novo, without any prior biological knowledge (e.g. pathways or protein interactions). CoMEt searches for combinations of mutations that exhibit mutual exclusivity, a pattern expected for mutations in pathways. CoMEt has several important feature that distinguish it from existing approaches to analyze mutual exclusivity among alterations. These include: an exact statistical test for mutual exclusivity that is more sensitive in detecting combinations containing rare alterations; simultaneous identification of collections of one or more combinations of mutually exclusive alterations; simultaneous analysis of subtype-specific mutations; and summarization over an ensemble of collections of mutually exclusive alterations. These features enable CoMEt to robustly identify alterations affecting multiple pathways, or hallmarks of cancer. We show that CoMEt outperforms existing approaches on simulated and real data. Application of CoMEt to hundreds of samples from four different cancer types from TCGA reveals multiple mutually exclusive sets within each cancer type. Many of these overlap known pathways, but others reveal novel putative cancer genes. *Equal contribution.Keywords
All Related Versions
This publication has 22 references indexed in Scilit:
- Advances for studying clonal evolution in cancerCancer Letters, 2013
- Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumoursBreast Cancer Research and Treatment, 2011
- Cleavage of E-cadherin by ADAM10 mediates epithelial cell sorting downstream of EphB signallingNature Cell Biology, 2011
- NPAS3 Demonstrates Features of a Tumor Suppressive Role in Driving the Progression of AstrocytomasThe American Journal of Pathology, 2011
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic DifferentiationCancer Cell, 2010
- Inhibition of Histone Deacetylase 10 Induces Thioredoxin-Interacting Protein and Causes Accumulation of Reactive Oxygen Species in SNU-620 Human Gastric Cancer CellsMolecules and Cells, 2010
- An approximation algorithm for counting contingency tablesRandom Structures & Algorithms, 2010
- Cadherins and catenins in breast cancerCurrent Opinion in Cell Biology, 2005
- DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3–26.1 is deleted in malignant brain tumoursNature Genetics, 1997
- Comparing partitionsJournal of Classification, 1985